Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium molybdate is an inorganic compound with the formula Na₂MoO₄. It is a white crystalline salt commonly encountered as the dihydrate form. Sodium molybdate serves as a source of the essential trace element molybdenum and is used in various industries including agriculture (as a fertilizer to treat or prevent plant deficiencies), water treatment (as a corrosion inhibitor), and health/nutrition (in supplements for preventing or treating dietary deficiencies). In medicine and nutrition, it may be used to address conditions related to low dietary intake of molybdenum or copper deficiency. Its mechanism of action in biological systems involves serving as a cofactor for enzymes such as sulfite oxidase that require the element for proper function[2][4][8]. High doses can cause toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium molybdate.